Novavax Inc SEC filings NVAX
Novavax Inc has 1,003 filings in SEC EDGAR's recent list, going back to Feb 14, 2013. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Aug 6, 2026 | — |
| S-8 | Employee stock plan registration | Aug 8, 2024 | — |
| S-8 | Employee stock plan registration | Aug 8, 2023 | — |
| 424B5 | Prospectus supplement | Aug 8, 2023 | — |
| S-3ASR | Automatic shelf registration | Feb 28, 2023 | — |
| S-8 | Employee stock plan registration | Jan 20, 2023 | — |
| 424B5 | Prospectus supplement | Dec 19, 2022 | — |
| FWP | Free writing prospectus | Dec 16, 2022 | — |
| 424B5 | Prospectus supplement | Dec 14, 2022 | — |
| S-8 | Employee stock plan registration | Aug 9, 2022 | — |
| S-8 | Employee stock plan registration | Aug 5, 2021 | — |
| 424B5 | Prospectus supplement | Jun 15, 2021 | — |
| 424B5 | Prospectus supplement | Jan 22, 2021 | — |
| 424B5 | Prospectus supplement | Nov 10, 2020 | — |
| 424B5 | Prospectus supplement | Nov 10, 2020 | — |
| 424B7 | Filing | Aug 10, 2020 | — |
| S-8 | Employee stock plan registration | Aug 10, 2020 | — |
| 424B5 | Prospectus supplement | May 18, 2020 | — |
| S-3ASR | Automatic shelf registration | Mar 11, 2020 | — |
| 424B5 | Prospectus supplement | Mar 2, 2020 | — |
| 424B5 | Prospectus supplement | Jan 21, 2020 | — |
| S-3 | Shelf registration | Dec 31, 2019 | — |
| S-8 | Employee stock plan registration | Aug 8, 2019 | — |
| 424B5 | Prospectus supplement | Dec 31, 2018 | — |
| S-8 | Employee stock plan registration | Aug 1, 2018 | — |
| 424B5 | Prospectus supplement | Apr 13, 2018 | — |
| 424B5 | Prospectus supplement | Apr 11, 2018 | — |
| S-3 | Shelf registration | Dec 29, 2017 | — |
| 424B5 | Prospectus supplement | Dec 29, 2017 | — |
| S-8 | Employee stock plan registration | Aug 9, 2017 | — |
| S-3/A | Filing | Jan 13, 2017 | — |
| S-3 | Shelf registration | Dec 30, 2016 | — |
| S-8 | Employee stock plan registration | Aug 11, 2016 | — |
| S-8 | Employee stock plan registration | Aug 13, 2015 | — |
| 424B5 | Prospectus supplement | Mar 26, 2015 | — |
| 424B5 | Prospectus supplement | Mar 24, 2015 | — |
| S-8 | Employee stock plan registration | Aug 13, 2014 | — |
| 424B2 | Prospectus | Jun 9, 2014 | — |
| 424B5 | Prospectus supplement | Jun 4, 2014 | — |
| S-3ASR | Automatic shelf registration | Jan 24, 2014 | — |
| 424B5 | Prospectus supplement | Sep 24, 2013 | — |
| 424B5 | Prospectus supplement | Sep 24, 2013 | — |
| S-8 | Employee stock plan registration | Aug 13, 2013 | — |
| S-8 | Employee stock plan registration | Aug 13, 2013 | — |
| 424B5 | Prospectus supplement | Jul 9, 2013 | — |
| S-4 | Registration for a merger or exchange | Jun 17, 2013 | — |
| S-3 | Shelf registration | Mar 14, 2013 | — |
Showing 47 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- NVAX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Gaithersburg, MD
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1000694
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.